Chemical Structure (Betamethasone 01)
Betamethasone Valerate Aerosol, Foam
Product Images NDC 51672-4188
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Betamethasone Valerate (NDC 51672-4188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Betamethasone 02)
Figure (Betamethasone 03)
Figure (Betamethasone 04)
Figure (Betamethasone 05)
Principal Display Panel (50 g Can Carton)
This is a description of a medication called Betamethasone Valerate solution. It is to be used for dermatologic (skin-related) purposes only and is not intended for ophthalmic (eye-related) use. The medication comes in the form of foam and should be kept out of the reach of children. The medication contains 1.2 mg of betamethasone valerate per gram and consists of various chemicals including alcohol, potassium chloride, and purified water. Users should apply the medication twice daily, following the instructions on the package insert, taking care to avoid contact with the eyes and other mucous membranes. The medication is flammable, under pressure, and should be kept away from heat. The manufacturer of this medication is Taro Pharmaceuticals. Side effects should be reported to the manufacturer.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
